Global Bioinformatics Market Outlook : Market Research Report

Global Bioinformatics Market Outlook

Published by: RNCOS

Published: Sep. 1, 2007 - 65 Pages

1. Analyst View

2. Emergence of Bioinformatics

2.1 Growth in Information Technology & Internet

2.2 Rising Costs & Timelines in Drug Delivery

2.3 Dwindling Drug Pipelines & Patent Expirations

2.4 Efficient Storage & Analysis of Research Data

3. Global Bioinformatics Market

3.1 Current & Future Scenario

3.2 By Region

3.2.1 US

3.2.2 Europe

3.2.3 Asia-Pacific

3.2.3.1 Japan

3.2.3.2 India

3.2.3.3 China

3.2.3.4 South Korea

3.2.3.5 Taiwan

3.2.3.6 Singapore

3.2.3.7 Australia

3.3 By Segment

3.3.1 Analysis Software & Services Market

3.3.2 Content Market

3.3.3 IT Infrastructure & Other Services Market

3.4 By Application

3.4.1 Genomics

3.4.2 Proteomics

3.4.3 Pharmacogenomics

3.4.4 Drug Discovery & Cheminformatics

4. Industry Analysis

4.1 Opportunities

4.1.1 Pharmaceutical & Biopharmaceutical Industry

4.1.2 Agri-biotechnology & Industrial Biotechnology Industry

4.1.3 Bioinformatics Outsourcing

4.1.4 Drug Delivery Market

4.2 Challenges

4.2.1 Lack of Standardization

4.2.2 Patent-related Issues

4.2.3 Limited User Base

5. Key Players

5.1 Accelrys, Inc.

5.2 Affymetrix, Inc.

5.3 Applied Biosystems Group

5.4 Celera Genomics Group

5.5 Ciphergen Biosystems

5.6 Compugen Ltd.

5.7 CuraGen Corporation

5.8 Gene Logic Inc.

5.9 IBM Life Sciences

5.10 Incyte Corporation

5.11 Tripos, Inc.

List of Figures:

Figure 2-1: Reduction in Time & Cost (%) by Using Computer Aided Drug Design Method

Figure 2-2: Worldwide - Forecast for Number of Drugs Facing Patent Expirations* (2007-2011)

Figure 2-3: Worldwide - Forecast for Loss due to Drug Patent Expirations* (in Billion US$), 2007-2011

Figure 3-1: Worldwide - Bioinformatics Market (in Million US$), 2002-2006E

Figure 3-2: Worldwide - Forecast for Bioinformatics Market (in Million US$), 2007-2010

Figure 3-3: US - Share in Global Bioinformatics Market (%), 2007F

Figure 3-4: Europe - Bioinformatics Market (in Million US$), 2004 & 2006

Figure 3-5: Europe - Percentage of R&D Spending & Drugs in Pipeline by Company Size, 2004

Figure 3-6: Europe - Forecast for Bioinformatics Market (in Million US$), 2007-2013

Figure 3-7: Japan - Bioinformatics Market (in Billion Yen), 2001-2003

Figure 3-8: India - Bioinformatics Market (in Rs Crore), 2002-03 to 2006-07

Figure 3-9: India - Share of Exports & Domestic Use in Bioinformatics Market (%), 2006-07

Figure 3-10: South Korea - Bioinformatics Market, Exports & Imports (in ‘000 US$), 2004

Figure 3-11: Taiwan - Bioinformatics Market (in Million US$), 2001-2003E & 2006E

Figure 3-12: Taiwan - Bioinformatics Market Imports (in Million US$), 2001-2003E & 2006E

Figure 3-13: Australia - Biotech Companies by Sector (%), 2006

Figure 3-14: Worldwide - Bioinformatics Market by Product (%), 2006E

Figure 3-15: Worldwide - Forecast for Bioinformatics Market by Product (%), 2010

Figure 3-16: Worldwide - Analysis Software & Services Market (in Million US$), 2005 & 2006E

Figure 3-17: Worldwide - Forecast for Analysis Software & Services Market (in Million US$), 2007 -2010

Figure 3-18: Worldwide - Analysis Software & Services Market by Application (%), 2006E

Figure 3-19: Worldwide - Forecast for Analysis Software & Services Market by Application (%), 2009

Figure 3-20: Worldwide - Content Market (in Million US$), 2005 & 2006E

Figure 3-21: Worldwide - Forecast for Content Market (in Million US$), 2007-2010

Figure 3-22: Worldwide - IT Infrastructure & Other Services Market (in Million US$), 2005 & 2006E

Figure 3-23: Worldwide - Forecast for IT Infrastructure & Other Services Market (in Million US$), 2007-2010

Figure 3-24: Worldwide - Bioinformatics Market by Application (%), 2001

Figure 3-25: Worldwide - Genomics Market (in Billion US$) 2002 & 2006E

Figure 3-26: Worldwide - Forecast for Genomics Market (in Billion US$), 2007-2009

Figure 3-27: Worldwide - DNA Sequencing & Proteomics Market (in Billion US$), 2004-2006E

Figure 3-28: Worldwide - Forecast for DNA Sequencing & Proteomics Market (in Billion US$), 2007-2009

Figure 3-29: Worldwide - Application of Proteomics in Bioinformatics Market (in Million US$), 2005-2007

Figure 3-30: Worldwide - Pharmacogenomics Market by Core Segment (in Million US$), 2004-2006E

Figure 3-31: Worldwide - Forecast for Pharmacogenomics Market by Core Segment (in Million US$), 2007-2009

Figure 3-32: Worldwide - Pharmacogenomics Market (in Million US$), 2004-2006E

Figure 3-33: Worldwide - Forecast for Pharmacogenomics Market (in Million US$), 2007-2009

Figure 3-34: Worldwide - Application of Pharmacogenomics in Bioinformatics Market (in Million US$), 2005-2007

Figure 3-35: Worldwide - Drug Discovery Expenditure (in Billion US$), 2002 & 2006E

Figure 4-1: Worldwide - Drug Delivery Market (in Billion US$), 2005 & 2006E

Figure 4-2: Worldwide - Forecast for Drug Delivery Market (in Billion US$), 2007-2010

List of Tables:

Table 3-1: Growth in Key Bioinformatics Databases (December 2004 & December 2005)

Table 5-1: Accelrys, Inc. - Key Financials (in Million US$), 2005-2007

Table 5-2: Affymetrix, Inc. - Key Financials (in Million US$), 2004-2006

Table 5-3: Applied Biosystems Group - Key Financials (in Million US$), 2004-2006

Table 5-4: Celera Genomics Group - Key Financials (in Million US$), 2004-2006

Table 5-5: Ciphergen Biosystems - Key Financials (in Millions US$), 2004-2006

Table 5-6: Compugen Ltd. - Key Financials (in Million US$), 2004-2006

Table 5-7: CuraGen Corporation - Key Financials (in Million US$), 2004-2006

Table 5-8: Gene Logic Inc. - Key Financials (in Million US$), 2004-2006

Table 5-9: Incyte Corporation - Key Financials (in Million US$), 2004-2006

Table 5-10: Tripos, Inc. - Key Financials (in Million US$), 2004-2006

Abstract

The research report "Global Bioinformatics Market Outlook” provides an updated and detailed overview of the worldwide Bioinformatics industry. It examines the emerging trends of the market and provides exclusive forecasts, market revenue of different product categories, and snapshots of different players in the industry.

The global Bioinformatics industry has grown at a double-digit growth rate in the past and is expected to follow the same pattern in the next four years. US remains the largest market in the world, but Asia-Pacific countries, particularly India and China, are witnessing the fastest growth and are anticipated to emerge as the dominating forces in future.

The content database market, with revenues of over US$ 800 Million in 2006, represents the largest segment in the market; however, it is the analytical software segment that is posting the fastest growth rate.

Bioinformatics is full of opportunities. The sector is poised to open new avenues for the other related sectors also. But the biggest opportunity area in the Bioinformatics market will be in the drug discovery sector. Reduction of both the cost and time taken to discover a new drug due to fast development in the Bioinformatics tools and software zone is also making drug discovery an attractive field to venture in.

Key Findings

Genomics occupies the largest share out of the various Bioinformatics application areas, however, proteomics take the lead.
Phenomenal development in Information Technology (IT) and the Internet have fuelled the growth of the Bioinformatics industry.
By using computer-aided drug design, drug-designing companies can save over 30% in both the cost and time to discover a new drug.
Patent protection and lack of standardization remain the biggest challenge for the Bioinformatics industry.

Key Issues and Facts Analyzed

Evaluation of past, current and future market trends.
Discussion of the major segments in the Bioinformatics market.
An analysis of the major regions in the Bioinformatics market.
Future prospects of the Bioinformatics market.
Key application areas of the market.
Profile discussion of key players in this sector.

Key Players Analyzed

This section provides an overview and key financial information of prominent players of the Bioinformatics market like IBM Life Sciences, Accelrys, Affymetrix, Applied Biosystems Group, Compugen Ltd, Ciphergen Biosystems, CuraGen Corporation, Celera Genomics Group, , Incyte Corporation and Tripos Inc.

Research Methodology Used

Information Sources The information provided in the report has been sourced credible sources like books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

Analysis Methods
The analysis methods includes ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.

For the purpose of this report, the following segments have been considered as a part of the Bioinformatics market:

Analysis software and services, Content market and IT Infrastructure and services market

The following currency conversion has been taken in the report:
1 US$ = INR 40.81, AUS$ 1.18, €0.74, RMB 8.27

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Global Bioinformatics Market Outlook

Table of Contents

Abstract